Insys agrees to pay $4.5 million to resolve Illinois opioid lawsuit

(Reuters) - Insys Therapeutics Inc has agreed to pay $4.5 million to resolve a lawsuit by Illinois' attorney general claiming it deceptively marketed a highly addictive fentanyl-based cancer pain drug for off-label uses.